| ETS2 |
ETS2: Protein C-ets-2 |
CEBPB |
CEBPB, TCF5, PP9092: CCAAT/enhancer-binding protein beta |
0.265 |
Evidence |
|
| ETS1 |
ETS1, EWSR2: Protein C-ets-1 |
BATF |
BATF: Basic leucine zipper transcriptional factor ATF-like |
0.265 |
Evidence |
|
| POU2F1 |
POU2F1, OCT1, OTF1: POU domain, class 2, transcription factor 1 |
BAZ2A |
BAZ2A, KIAA0314, TIP5: Bromodomain adjacent to zinc finger domain protein 2A |
0.265 |
Evidence |
|
| POU2F1 |
POU2F1, OCT1, OTF1: POU domain, class 2, transcription factor 1 |
SAFB |
SAFB, HAP, HET, SAFB1: Scaffold attachment factor B |
0.265 |
Evidence |
|
| IL2RB |
IL2RB: Interleukin-2 receptor subunit beta precursor |
IL12RB2 |
IL12RB2: Interleukin-12 receptor beta-2 chain precursor |
0.265 |
Evidence |
|
| IL2RB |
IL2RB: Interleukin-2 receptor subunit beta precursor |
IL10RA |
IL10RA, IL10R: Interleukin-10 receptor alpha chain precursor |
0.265 |
Evidence |
|
| HSP90B1 |
HSP90B1, TRA1: Endoplasmin precursor |
HLA-DMA |
DMA, HLA-DMA, DAQB-96B10.1-001, DASS-67H14.8-001, XXbac-BCX136A3.1-001, XXbac-BP |
0.265 |
Evidence |
|
| HSP90B1 |
HSP90B1, TRA1: Endoplasmin precursor |
HLA-DPB1 |
HLA-DPB1: MHC class II lymphocyte antigen beta chain precursor |
0.265 |
Evidence |
|
| PRKG1 |
PRKG1, PRKG1B, PRKGR1B: cGMP-dependent protein kinase 1, beta isozyme |
IRS2 |
IRS2: Insulin receptor substrate 2 |
0.265 |
Evidence |
|
| NCF1 |
Neutrophil cytosolic factor 1 variant (Fragment) |
IQSEC1 |
IQSEC1, ARFGEP100, BRAG2, KIAA0763: IQ motif and Sec7 domain-containing protein |
0.265 |
Evidence |
|
| NCF1 |
Neutrophil cytosolic factor 1 variant (Fragment) |
STK24 |
STK24, MST3, STK3: Serine/threonine-protein kinase 24 |
0.265 |
Evidence |
|
| NCF1 |
Neutrophil cytosolic factor 1 variant (Fragment) |
STK38L |
STK38L, KIAA0965, NDR2: Serine/threonine-protein kinase 38-like |
0.265 |
Evidence |
|
| NCF1 |
Neutrophil cytosolic factor 1 variant (Fragment) |
GAB2 |
IPI00186990 |
0.265 |
Evidence |
|
| NCF1 |
Neutrophil cytosolic factor 1 variant (Fragment) |
MAP3K11 |
MAP3K11, MLK3, PTK1, SPRK: Mitogen-activated protein kinase kinase kinase 11 |
0.265 |
Evidence |
|
| HCLS1 |
HCLS1, HS1: Hematopoietic lineage cell-specific protein |
IRS2 |
IRS2: Insulin receptor substrate 2 |
0.265 |
Evidence |
|
| HCLS1 |
HCLS1, HS1: Hematopoietic lineage cell-specific protein |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
0.265 |
Evidence |
|
| HCLS1 |
HCLS1, HS1: Hematopoietic lineage cell-specific protein |
GAB2 |
IPI00186990 |
0.265 |
Evidence |
|
| CD59 |
CD59, MIC11, MIN1, MIN2, MIN3, MSK21: CD59 glycoprotein precursor |
TEK |
TEK, TIE2: Angiopoietin-1 receptor precursor |
0.265 |
Evidence |
|
| GTF2F2 |
IPI00329767 |
CCNB1 |
Cyclin B1 |
0.265 |
Evidence |
|
| GTF2F2 |
IPI00329767 |
TRIM28 |
TRIM28, KAP1, RNF96, TIF1B: Transcription intermediary factor 1-beta |
0.265 |
Evidence |
|
| GTF2F2 |
IPI00329767 |
SMARCA4 |
SMARCA4, BRG1, SNF2B, SNF2L4: Probable global transcription activator SNF2L4 |
0.265 |
Evidence |
|
| LCP1 |
LCP1, PLS2: Plastin-2 |
ZYX |
ZYX: Zyxin |
0.265 |
Evidence |
|
| LCP1 |
LCP1, PLS2: Plastin-2 |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
0.265 |
Evidence |
|
| PRG2 |
PRG2, MBP: Bone marrow proteoglycan precursor |
COL15A1 |
COL15A1: Collagen alpha-1(XV) chain precursor [Contains: Endostatin |
0.265 |
Evidence |
|
| F3 |
F3: Tissue factor precursor |
TNC |
TNC, HXB: Tenascin precursor |
0.265 |
Evidence |
|